Protein Information

General Information of the Protein

Protein ID	PT00835
Protein Name	Histone deacetylase 2
Secondarily Protein Name	Protein deacylase HDAC2
Gene Name	HDAC2
Sequence	MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYMEKIKQRLFENLRMLPHAPGVQMQAIPEDAVHEDSGDEDGEDPDKRISIRASDKRIACDEEFSDSEDEGEGGRRNVADHKKGAKKARIEEDKKETEDKKTDVKEEDKSKDNSGEKTDTKGTKSEQLSNP Show/Hide
Organism	Homo sapiens, Human
Protein Classification	Epigenetic regulator > Eraser > Histone deacetylase > HDAC class I
Function	Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed:28497810). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (By similarity). Histone deacetylases act via the formation of large multiprotein complexes (By similarity). Forms transcriptional repressor complexes by associating with MAD, SIN3, YY1 and N-COR (PubMed:12724404). Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development (By similarity). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:16428440, PubMed:28977666). Also deacetylates non-histone targets: deacetylates TSHZ3, thereby regulating its transcriptional repressor activity (PubMed:19343227). May be involved in the transcriptional repression of circadian target genes, such as PER1, mediated by CRY1 through histone deacetylation (By similarity). Involved in MTA1-mediated transcriptional corepression of TFF1 and CDKN1A (PubMed:21965678). In addition to protein deacetylase activity, also acts as a protein-lysine deacylase by recognizing other acyl groups: catalyzes removal of (2E)-butenoyl (crotonyl) and 2-hydroxyisobutanoyl (2-hydroxyisobutyryl) acyl groups from lysine residues, leading to protein decrotonylation and de-2-hydroxyisobutyrylation, respectively (PubMed:28497810, PubMed:29192674). Show/Hide
Uniprot ID	Primary ID: Q92769 Secondarily ID: B3KRS5 B4DL58 E1P561 Q5SRI8 Q5SZ86 Q8NEH4 Show/Hide
Ensembl ID	ENSG00000196591
HGNC ID	HGNC:4853
Subcellular Location	Nucleus Cytoplasm

Map of Molecular Bioactivity Related to the Protein

Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity

Table of Molecular Bioactivities Related to the Protein

Cell Line ID: CL000023 , BTI-Tn-5B1-4

Cell Line Info

Compound ID	Compound Name	Compound Formula
CP0444962 Compound Info	5-cyclopropyl-N-[(1S)-1-[4-(hydroxycarbamoyl)phenyl]ethyl]-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide Show/Hide	C25H22N4O3S2	1
1	IC50 = 13.26 nM Bioactivity Info	TI LI LO TS
CP0003580 Compound Info	Faridak Show/Hide	C21H23N3O2	1
1	IC50 = 22.83 nM Bioactivity Info	TI LI LO TS
CP0016939 Compound Info	N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide Show/Hide	C23H20N6O	1
1	IC50 = 170 nM Bioactivity Info	TI LI LO TS
CP0445497 Compound Info	1-N-(2-amino-5-thiophen-2-ylphenyl)-3-N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]benzene-1,3-dicarboxamide Show/Hide	C38H35N3O7S	1
1	IC50 = 190 nM Bioactivity Info	TI LI LO TS
CP0389602 Compound Info	N-(2-amino-5-thiophen-2-ylphenyl)-4-[[[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]amino]methyl]benzamide Show/Hide	C38H37N3O6S	1
1	IC50 = 270 nM Bioactivity Info	TI LI LO TS
CP0445496 Compound Info	4-N-(2-amino-5-thiophen-2-ylphenyl)-1-N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]benzene-1,4-dicarboxamide Show/Hide	C38H35N3O7S	1
1	IC50 = 380 nM Bioactivity Info	TI LI LO TS
CP0428790 Compound Info	1-N-(2-aminophenyl)-3-N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]benzene-1,3-dicarboxamide Show/Hide	C34H33N3O7	1
1	IC50 = 4910 nM Bioactivity Info	TI LI LO TS
CP0389603 Compound Info	N-(2-amino-5-thiophen-2-ylphenyl)-3-[[[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]amino]methyl]benzamide Show/Hide	C38H37N3O6S	1
1	IC50 = 5410 nM Bioactivity Info	TI LI LO TS
CP0387069 Compound Info	N-(2-aminophenyl)-4-[[[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]amino]methyl]benzamide Show/Hide	C34H35N3O6	1
1	IC50 = 6730 nM Bioactivity Info	TI LI LO TS
CP0387070 Compound Info	4-N-(2-aminophenyl)-1-N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]benzene-1,4-dicarboxamide Show/Hide	C34H33N3O7	1
1	IC50 = 10420 nM Bioactivity Info	TI LI LO TS
CP0389601 Compound Info	N-(2-aminophenyl)-3-[[[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]amino]methyl]benzamide Show/Hide	C34H35N3O6	1
1	IC50 > 34383.75711 nM Bioactivity Info	TI LI LO TS
CP0037274 Compound Info	(S)-N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide Show/Hide	C22H25NO6	1
1	IC50 > 50070.09814 nM Bioactivity Info	TI LI LO TS

Cell Line ID: CL000006 , HEK293

Cell Line Info

Cell Line ID: CL000131 , HEK293-F

Cell Line Info

Cell Line ID: CL000017 , HeLa

Cell Line Info

Cell Line ID: CL000162 , HeLa S3

Cell Line Info

Cell Line ID: CL000012 , Sf21

Cell Line Info

Cell Line ID: CL000013 , Sf9

Cell Line Info

Biochemical Assays

Compound ID	Compound Name	Compound Formula
CP0008777 Compound Info	JNJ-26481585 Show/Hide	C21H26N6O2	5
1	IC50 = 0.33 nM
2	IC50 = 4.26 nM
3	IC50 = 5 nM
4	Ki = 0.06 nM
5	Ki = 31 nM
CP0004955 Compound Info	(5R,8S,11S)-5-methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-triene-6,9,13-trione Show/Hide	C21H28N4O4S3	2
1	IC50 = 0.9 nM
2	IC50 = 4.19 nM
CP0005479 Compound Info	CHEBI:46024 Show/Hide	C17H22N2O3	28
1	IC50 = 1 nM
2	IC50 = 1.1 nM
3	IC50 = 4 nM
4	IC50 = 6.08 nM
5	IC50 = 10 nM
6	IC50 = 14 nM
7	IC50 = 14.8 nM
8	IC50 = 15 nM
9	IC50 = 18 nM
10	IC50 = 20.5 nM
11	IC50 = 22.95 nM
12	IC50 = 23 nM
13	IC50 = 23.6 nM
14	IC50 = 24 nM
15	IC50 = 25 nM
16	IC50 = 28.2 nM
17	IC50 = 32.1 nM
18	IC50 = 39 nM
19	IC50 = 39.1 nM
20	IC50 = 46.6 nM
21	IC50 = 52 nM
22	IC50 = 68 nM
23	IC50 = 96 nM
24	IC50 = 7600 nM
25	Ki = 0.65 nM
26	Ki = 0.7 nM
27	Ki = 0.76 nM
28	Ki = 1.06 nM
CP0085832 Compound Info	(1R,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone Show/Hide	C24H36N4O6S2	3
1	IC50 = 1 nM
2	IC50 = 3.9 nM
3	IC50 = 47 nM
CP0004988 Compound Info	pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate Show/Hide	C21H20N4O3	21
1	IC50 = 1.2 nM
2	IC50 = 15 nM
3	IC50 = 250 nM
4	IC50 = 340 nM
5	IC50 = 396 nM
6	IC50 = 400 nM
7	IC50 = 410 nM
8	IC50 = 480 nM
9	IC50 = 500 nM
10	IC50 = 505 nM
11	IC50 = 613 nM
12	IC50 = 650 nM
13	IC50 = 720 nM
14	IC50 = 740 nM
15	IC50 = 1000 nM
16	IC50 = 1510 nM
17	IC50 < 300 nM
18	Ki = 6 nM
19	Ki = 65 nM
20	Ki = 73 nM
21	Ki = 590 nM
CP0832315 Compound Info	(S)-6-methyl-N-((S)-1-(5-(2-methyl-1-oxo-1,2-dihydroisoquinolin-6-yl)-1H-imidazol-2-yl)-7-oxononyl)-6-azaspiro[2.5]octane-1-carboxamide Show/Hide	C31H41N5O3	1
1	IC50 = 1.6 nM
CP0003832 Compound Info	N'-hydroxy-N-phenyloctanediamide Show/Hide	C14H20N2O3	96
1	IC50 = 1.7 nM
2	IC50 = 10 nM
3	IC50 = 10.2 nM
4	IC50 = 11 nM
5	IC50 = 12 nM
6	IC50 = 13 nM
7	IC50 = 15 nM
8	IC50 = 16 nM
9	IC50 = 17 nM
10	IC50 = 18 nM
11	IC50 = 19 nM
12	IC50 = 21.61 nM
13	IC50 = 24 nM
14	IC50 = 26 nM
15	IC50 = 27 nM
16	IC50 = 28 nM
17	IC50 = 32 nM
18	IC50 = 33 nM
19	IC50 = 35 nM
20	IC50 = 36 nM
21	IC50 = 40 nM
22	IC50 = 52 nM
23	IC50 = 56 nM
24	IC50 = 66 nM
25	IC50 = 72 nM
26	IC50 = 73 nM
27	IC50 = 76 nM
28	IC50 = 82 nM
29	IC50 = 85.8 nM
30	IC50 = 89.23 nM
31	IC50 = 90 nM
32	IC50 = 93.22 nM
33	IC50 = 93.6 nM
34	IC50 = 96 nM
35	IC50 = 98.47 nM
36	IC50 = 100 nM
37	IC50 = 100.9 nM
38	IC50 = 110 nM
39	IC50 = 112.5 nM
40	IC50 = 114 nM
41	IC50 = 118 nM
42	IC50 = 120 nM
43	IC50 = 123.7 nM
44	IC50 = 128.9 nM
45	IC50 = 135 nM
46	IC50 = 137.2 nM
47	IC50 = 140 nM
48	IC50 = 149 nM
49	IC50 = 150 nM
50	IC50 = 153.1 nM
51	IC50 = 154.6 nM
52	IC50 = 156 nM
53	IC50 = 160 nM
54	IC50 = 163.6 nM
55	IC50 = 164 nM
56	IC50 = 167 nM
57	IC50 = 170 nM
58	IC50 = 173 nM
59	IC50 = 174.6 nM
60	IC50 = 176 nM
61	IC50 = 178 nM
62	IC50 = 180 nM
63	IC50 = 182 nM
64	IC50 = 184.7 nM
65	IC50 = 193 nM
66	IC50 = 197 nM
67	IC50 = 200 nM
68	IC50 = 210 nM
69	IC50 = 213 nM
70	IC50 = 220 nM
71	IC50 = 232 nM
72	IC50 = 240 nM
73	IC50 = 250 nM
74	IC50 = 256 nM
75	IC50 = 260 nM
76	IC50 = 280 nM
77	IC50 = 282 nM
78	IC50 = 332.65 nM
79	IC50 = 390 nM
80	IC50 = 400 nM
81	IC50 = 410 nM
82	IC50 = 411 nM
83	IC50 = 454 nM
84	IC50 = 550 nM
85	IC50 = 760 nM
86	IC50 = 780 nM
87	IC50 = 920 nM
88	IC50 = 921 nM
89	IC50 >= 50 nM
90	IC50 > 200 nM
91	Ki = 1.6 nM
92	Ki = 7 nM
93	Ki = 8 nM
94	Ki = 40 nM
95	Ki = 42 nM
96	Ki = 90 nM
CP0826898 Compound Info	(S)-6-methyl-N-((S)-7-oxo-1-(5-(quinolin-3-yl)-1H-imidazol-2-yl)nonyl)-6-azaspiro[2.5]octane-1-carboxamide Show/Hide	C30H39N5O2	2
1	IC50 = 2.3 nM
2	IC50 = 4.2 nM
CP0003580 Compound Info	Faridak Show/Hide	C21H23N3O2	9
1	IC50 = 3 nM
2	IC50 = 6.8 nM
3	IC50 = 13.2 nM
4	IC50 = 136 nM
5	IC50 < 300 nM
6	Ki = 0.65 nM
7	Ki = 0.7 nM
8	Ki = 1.9 nM
9	Ki = 22 nM
CP0115609 Compound Info	N-hydroxy-2-[2-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyethyl-methylamino]pyrimidine-5-carboxamide Show/Hide	C23H23N7O4	1
1	IC50 = 3.4 nM
CP0003676 Compound Info	N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide Show/Hide	C23H24N8O4S	2
1	IC50 = 5 nM
2	IC50 = 8 nM
CP0044706 Compound Info	(2E)-N-hydroxy-3-(4-{[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl}phenyl)prop-2-enamide Show/Hide	C22H25N3O3	3
1	IC50 = 7 nM
2	IC50 = 15.7 nM
3	Ki = 1.4 nM
CP0030986 Compound Info	N-(4-(2-propylhydrazine-1- carbonyl)benzyl)cinnamamide Show/Hide	C20H23N3O2	6
1	IC50 = 14 nM
2	IC50 = 24.8 nM
3	IC50 = 48 nM
4	IC50 = 89.9 nM
5	IC50 = 95.45 nM
6	Ki = 103 nM
CP0013907 Compound Info	US9145412, Table 1, Compound 23 Show/Hide	C24H23N5OS	1
1	IC50 = 15 nM
CP0637739 Compound Info	(S)-N-(1-(5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl)-7-oxononyl)-1-methylazetidine-3-carboxamide Show/Hide	C27H35N5O3	1
1	IC50 = 18 nM
CP0004959 Compound Info	S-[(E)-4-[(5R,8S,11S)-5-methyl-6,9,13-trioxo-8-propan-2-yl-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-trien-11-yl]but-3-enyl] octanethioate Show/Hide	C29H42N4O5S3	4
1	IC50 = 18.65 nM
2	IC50 = 64 nM
3	IC50 = 900 nM
4	IC50 = 1010 nM
CP0016939 Compound Info	N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide Show/Hide	C23H20N6O	5
1	IC50 = 22 nM
2	IC50 = 280 nM
3	IC50 = 283 nM
4	IC50 = 290 nM
5	Ki = 32.4 nM
CP0363242 Compound Info	US8609678, 2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide [89] Show/Hide	C24H26ClN5O3	1
1	IC50 = 45 nM
CP0004475 Compound Info	RICOLINOSTAT Show/Hide	C24H27N5O3	4
1	IC50 = 48 nM
2	IC50 = 95 nM
3	IC50 = 403 nM
4	Ki = 204 nM
CP0034844 Compound Info	HDAC inhibitor, Compound 1 Show/Hide	C19H17N3O2S	3
1	IC50 = 49 nM
2	IC50 = 100 nM
3	IC50 < 300 nM
CP0013235 Compound Info	(E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide Show/Hide	C20H32Cl2N4O2	2
1	IC50 = 290 nM
2	Ki = 27 nM
CP0010599 Compound Info	UF010 Show/Hide	C11H15BrN2O	1
1	IC50 = 322 nM
CP0007846 Compound Info	N-hydroxy-4-[(2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl)methyl]benzamide Show/Hide	C20H21N3O2	9
1	IC50 = 360 nM
2	IC50 = 3575 nM
3	IC50 = 3900 nM
4	IC50 = 6270 nM
5	IC50 = 8674.5 nM
6	IC50 = 19000 nM
7	IC50 > 3000 nM
8	IC50 > 5000 nM
9	IC50 > 30000 nM
CP0446185 Compound Info	[6-[2-[[4-(benzenesulfonyl)-5-oxido-1,2,5-oxadiazol-5-ium-3-yl]oxy]ethoxy]pyridin-3-yl]methyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate Show/Hide	C31H28N6O9S	1
1	IC50 = 370 nM
CP0013440 Compound Info	4-[(2-bromoacridin-9-yl)amino]-N-hydroxybenzamide Show/Hide	C20H14BrN3O2	1
1	IC50 = 480 nM
CP0014809 Compound Info	US10807944, Compound RLS3-43 Show/Hide	C17H20N2O	1
1	IC50 = 800 nM
CP0086044 Compound Info	(E)-N-hydroxy-3-(4-phenylphenyl)prop-2-enamide Show/Hide	C15H13NO2	1
1	IC50 = 820 nM
CP0014908 Compound Info	4-(acetylamino)-N-(2-amino-phenyl) benzamide Show/Hide	C15H15N3O2	5
1	IC50 = 900 nM
2	IC50 = 1200 nM
3	IC50 = 1920 nM
4	IC50 = 3850 nM
5	Ki = 190 nM
CP0053451 Compound Info	6-(2-Mercapto-acetylamino)-hexanoic acid quinolin-8-ylamide Show/Hide	C17H21N3O2S	1
1	IC50 = 1250 nM
CP0014659 Compound Info	N'-(2-aminophenyl)-N-phenylheptanediamide Show/Hide	C19H23N3O2	1
1	IC50 = 1590 nM
CP0014658 Compound Info	US9265734, R01 Show/Hide	C20H25N3O2	1
1	IC50 = 1980 nM
CP0068281 Compound Info	N-(2-aminophenyl)pyrazine-2-carboxamide Show/Hide	C11H10N4O	1
1	IC50 = 2362 nM
CP0053450 Compound Info	6-(3-adamantan-1-yl-ureido)hexanoic acid hydroxyamide Show/Hide	C17H29N3O3	1
1	IC50 = 2580 nM
CP0015005 Compound Info	S-[(E)-4-[(4Z,7S,10S)-4-ethylidene-2,5,8,12-tetraoxo-7-propan-2-yl-9-oxa-16-thia-3,6,13,18-tetrazabicyclo[13.2.1]octadeca-1(17),15(18)-dien-10-yl]but-3-enyl] octanethioate Show/Hide	C29H42N4O6S2	1
1	IC50 = 2710 nM
CP0057110 Compound Info	4-[[butyl(phenylcarbamoyl)amino]methyl]-N-hydroxybenzamide Show/Hide	C19H23N3O3	1
1	IC50 = 6920 nM
CP0007404 Compound Info	(E)-N-(2-amino-4-fluorophenyl)-3-[1-[(E)-3-phenylprop-2-enyl]pyrazol-4-yl]prop-2-enamide Show/Hide	C21H19FN4O	2
1	IC50 = 9700 nM
2	IC50 > 15000 nM
CP0528060 Compound Info	tert-butyl (E)-3-hydroxy-7-[[(E)-5-hydroxy-7-[(2-methylpropan-2-yl)oxy]-7-oxohept-3-enyl]disulfanyl]hept-4-enoate Show/Hide	C22H38O6S2	2
1	IC50 = 10000 nM
2	IC50 = 100000 nM
CP0053521 Compound Info	5-methyl-3-phenyl-N-[5-[(2-sulfanylacetyl)amino]pentyl]-1,2-oxazole-4-carboxamide Show/Hide	C18H23N3O3S	1
1	IC50 = 28000 nM
CP0014148 Compound Info	N-hydroxy-1-[(4-methoxyphenyl)methyl]indole-6-carboxamide Show/Hide	C17H16N2O3	3
1	IC50 > 20000 nM
2	IC50 > 50000 nM
3	IC50 > 100000 nM
CP0008165 Compound Info	N'-(2-aminophenyl)-N-[3-(1-phenyltriazol-4-yl)phenyl]octanediamide Show/Hide	C28H30N6O2	1
1	IC50 > 30000 nM
CP0013905 Compound Info	[6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate Show/Hide	C24H27N3O4	1
1	Ki = 3 nM
CP0008445 Compound Info	3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide Show/Hide	C21H23N3O5	2
1	Ki = 19 nM
2	Ki = 20 nM

Clinical Information about the Protein

Target 1 ( Histone deacetylase 2 (HDAC2) )

Target Type	Clinical trial Target
Disease	1 Target-related Disease				1
1	Solid tumour/cancer [ICD-11: 2A00-2F9Z]
Investigative Drug(s)	1 Investigative Drug				1
1	ST-2987	Drug Info	Investigative	Solid tumour/cancer

Target 2 ( HUMAN histone deacetylase 2 (HDAC2) )

Target Type	Unknown Type Target

Similar Protein(s) and Bioactivity Statistics

50% Identity

Protein ID	Protein Name	Protein Organism
PT00991	Histone deacetylase 1	Homo sapiens, Human	Protein Info
PT03901	Histone deacetylase 1	Mus musculus, Mouse	Protein Info

Cite

About MolBiC

Correspondence

Prof. Feng ZHU

Prof. Leo, Lianyi Han